AQR Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-7,798
| Closed | -$399K | – | 3161 |
|
|
2024
Q4 | $399K | Buy |
7,798
+230
| +3% | +$11.8K | ﹤0.01% | 2363 |
|
|
2024
Q3 | $387K | Buy |
7,568
+442
| +6% | +$22.6K | ﹤0.01% | 2282 |
|
|
2024
Q2 | $319K | Buy |
7,126
+227
| +3% | +$10.2K | ﹤0.01% | 2241 |
|
|
2024
Q1 | $323K | Buy |
6,899
+213
| +3% | +$9.97K | ﹤0.01% | 2105 |
|
|
2023
Q4 | $238K | Buy |
+6,686
| New | +$238K | ﹤0.01% | 2150 |
|
|
2022
Q3 | – | Sell |
-10,138
| Closed | -$189K | – | 2221 |
|
|
2022
Q2 | $189K | Sell |
10,138
-16,268
| -62% | -$303K | ﹤0.01% | 2003 |
|
|
2022
Q1 | $580K | Buy |
26,406
+1,742
| +7% | +$38.3K | ﹤0.01% | 1763 |
|
|
2021
Q4 | $701K | Buy |
+24,664
| New | +$701K | ﹤0.01% | 1711 |
|